WANA (Jul 27) – A cutting-edge technological platform is under development in Iran to precisely and efficiently deliver therapeutic cells to cancerous tissues, marking a significant step forward in enhancing the effectiveness of cell-based cancer treatments.

 

With the rapid advancement of novel technologies in the field of regenerative medicine, innovative approaches—particularly those based on cell therapy—are emerging as a promising frontier in global cancer treatment. Countries worldwide are leveraging smart technologies to create systems capable of guiding therapeutic cells accurately to tumor sites.

 

In line with this trend, Iranian experts are also working to design and implement advanced, locally developed versions of these technologies by combining indigenous knowledge with international experience.

 

One such expert, Dr. Fatemeh Zohtabi, a biomedical engineering specialist who recently returned from the United States, has brought her expertise back to Iran to contribute to the development of this novel platform. The initiative is being designed and executed in collaboration with a local knowledge-based company, supported by the innovation platform “Connect.”

 

Dr. Zohtabi, a member of the executive team behind the project, emphasized the importance of the technology:

 

“Our focus is on developing a system that can deliver therapeutic cells in a controlled and optimized manner directly to the tumor site. This approach could mark a turning point in more effective cancer treatments through regenerative medicine.”

 

She explained that her prior research in vascular diseases and oncology during her time in the U.S. laid the foundation for this idea. After returning to Iran, she partnered with Kian Imen Cell, a biotech company, to move the concept toward execution and commercialization.

 

“The Connect platform played a key role throughout this journey—from identifying expert networks and collaborative teams to facilitating legal pathways, attracting investment, and obtaining necessary permits,” she said. “We are now in the process of company registration and initiating formal procedures to bring the product to market.

 

Dr. Zohtabi also highlighted her participation in a Connect innovation event, describing it as a valuable opportunity for networking with investors, raw material suppliers, and technology stakeholders. “It helped us piece together the execution puzzle and move toward implementation.”

 

The Connect platform, established by the Vice-Presidency for Science, Technology, and Knowledge-Based Economy, aims to support innovative ideas, commercialize scientific achievements, and build connections across the innovation ecosystem. To date, it has supported dozens of projects on their journey from concept to product.